累计买入21亿！挖空心思操纵自家股价 金城医药董事长亏了739万

Core Viewpoint - The investigation into Jincheng Pharmaceutical's actual controller, Zhao Yeqing, concluded with his resignation on the same day the results were announced, revealing a stock manipulation case that resulted in significant losses despite extensive trading activity [2][7]. Group 1: Investigation and Findings - Jincheng Pharmaceutical announced the resignation of its chairman Zhao Yeqing and the receipt of an administrative penalty decision from the China Securities Regulatory Commission (CSRC) [2]. - The investigation revealed that from August 18, 2017, to February 10, 2020, Zhao Yeqing, along with Wang Zhen and Liu Feng, manipulated the company's stock using a network of 104 accounts over 595 trading days [3]. - The account group held an average of 18.58 million shares, representing 5.68% of the company's circulating shares, with a peak holding of 32.09 million shares, or 9.04% [3]. Group 2: Trading Activities and Impact - During the manipulation period, the account group engaged in "matched orders," significantly affecting stock prices, with a notable price increase of 21.30% from February 1 to April 26, 2018, while the ChiNext index only rose by 2.90% [3]. - The account group executed trades between their own controlled accounts for 214 days, with trading volume exceeding 10% of the market volume on 76 days, and reaching as high as 45.65% on one occasion [4]. Group 3: Penalties and Consequences - The CSRC imposed a total fine of 3 million yuan on the three individuals involved, with Zhao Yeqing receiving a fine of 1.5 million yuan and a four-year market ban [6]. - Zhao Yeqing's resignation was stated to be due to personal reasons, and the company emphasized that the administrative penalty only affected him personally and would not impact the company's operations [7].